News
November 2, 2026
Craig receives the 2026 Prelog Medal from the Laboratory of Organic Chemistry, ETH, Switzerland.
September 1, 2026
Michael Schottenhamel receives an ERP Predoctoral Fellowship from the Studienstiftung des deutschen Volkes.
May 1, 2026
Vepdegestrant/Veppanu is the first PROTAC to receive FDA approval.
March 1, 202
Anabel Sanchez Merino is awarded a postdoctoral fellowship from the Spanish Foundation Alfonso Martín Escudero.
January 1, 2026
Emily Williford receives a Postdoctoral Fellowship from the American Heart Association.
November 17, 2025
Halda Therapeutics is purchased by J&J based on early promising Phase I data with a prostate cancer-targeting RIPTAC
November 8, 2025
Craig receives the 2025 Inhoffen Medal from the Helmholtz Center and TU Braunschweig, Germany.
November 14, 2025
Craig receives the 2025 Havinga Medal from Leiden University.
March 15, 2025
Tom Corner receives a Lymphoma Research Foundation Postdoctoral Fellowship.
May 10, 2024
Ray Deshaies and Craig receive the 2025 Passano Award.
September 4, 2024
Craig receives the 2024 IUPAC-Richter Prize in Medicinal Chemistry for his "his discovery and implementation of the PROteolysis TArgeting Chimeras (PROTACs) technology".
May 13, 2024
Craig was selected to give the 2024 Emanuel Merck Lectureship for “his pioneering scientific work in the field of ’Targeted Protein Degradation’".
January 1, 2024
Mack Krone receives an American Cancer Society Postdoctoral Fellowship for his project entitled: "Development of Tumor Selective Protein Degraders for Precise Cancer Treatments".
December 5, 2023
Craig receives the Kimberly Prize for his "fundamental discoveries with broad impact on biology and medicine".
July 9, 2023
Craig receives the 2023 Gabbay Award with Ray Deshaies for their pioneering work in the field of Targeted Protein Degradation.
July 1st, 2023
Congratulations to Maxime Mivalez on receiving a Postdoc Mobility fellowship from the Swiss National Science Foundation.
April 21, 2023
Craig receives the Bristol Myers Squibb Award in Enzyme Chemistry from the American Chemical Society.
March 1st, 2023
Congratulations to Sisi Zheng on receiving a Predoctoral MD/PhD fellowship from the NIH.
May 1, 2023
Halda Therapeutics emerges from stealth mode with RITPACs, a new induced proximity modality
July 1st, 2022
Congratulations to Laura Santos on receiving a Fulbright fellowship.
May 16, 2022
Craig receives the 2022 Connecticut Medal of Technology for his pioneering work.
November 11, 2021
Craig is awarded the2021 Scheele Prize from the Swedish Pharmaceutical Society.
July 1st, 2021
Congratulations to Jacques Saarbach on receiving a Postdoc Mobility fellowship from the Swiss National Science Foundation.
July 1st, 2021
Congratulations to Inga Shchelik on receiving a Postdoc Mobility fellowship from the Swiss National Science Foundation.
October 15, 2020
Craig is awarded the 2020 Heinrich Wielend Prize, from the Boehringer Ingelheim Stiftung.
March 23, 2020
Congratulations to Elle An for receiving a NSF predoctoral fellowship.
October 10, 2019
Big Pharma Bets on Body’s Garbage-Disposal System to Beat Cancer
September 12, 2019
Congratulations to Cesar De Leon for being selected as a Howard Hughes Medical Institute (HHMI) Hanna Gray Fellow.
June 19, 2019
These Protein Picker-Uppers Keep Your Cells Clean and Healthy - Arvinas in the news.
March 20, 2019
Protein-slaying drugs could be the next blockbuster therapies. Nature News Feature - March 20, 2019
February 11, 2019
Craig awarded the 2019 Pharmacia-ASPET Award for Experimental Therapeutics.
July 25, 2018
Craig received the 2018 Pierre Fabre Award for Therapeutic Innovation.
July 25, 2018
Congratulations to Shanique Alabi and Mike Bond for their respective HHMI Gilliam and NIH F31 Pre-doctoral Fellowships!
May 8, 2018
Craig is awarded the 2018 Khorana Prize by the Royal Society of Chemistry.
February 28, 2017
Craig awarded the 2017 AACR Award for Outstanding Achievement in Chemistry in Cancer Research.
September 30, 2016
Congratulations to Grant Parker Flowers for being awarded the NIH Post-doctoral Fellowship.
September 16, 2016
Congratulations to Dan Bondeson who received a NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00).
September 16, 2016
John Hines has received the R50 Research Specialists Award from the National Cancer Institute.
January 31, 2016
Craig awarded $10M grant to launch PITCH, a new biotech accelerator program.
November 25, 2015
Craig receives the Yale Cancer Center Translational Research Prize.
October 16, 2015
Craig receives an inaugural National Cancer Institute R35 Outstanding Investigator Award (OIA).
September 30, 2015
Congratulations to Parker Grant Flowers for being awarded the Connecticut Regenerative Medicine Research Fund Seed Grant.
June 10, 2015
New type of drug can target all disease-causing proteins.
April 21, 2015
Congratulations to Jemilat Salami who received a NSF Pre-Doctoral Fellowship.
December 31, 2014
Doris Hellerschmeid-Jelinek was awarded an EMBO Long-term Fellowship to support her postdoctoral training in the Crews Lab.
August 22, 2014
Crews awarded UCB-Ehrlich Award for work on anti-cancer therapy
December 4, 2013
Craig has received CURE’s inaugural Entrepreneur of the Year Award.
December 2, 2013
Craig Crews has been named a Fellow of the American Association for the Advancement of Science (AAAS) for “distinguished contributions to the field of chemical biology and particularly for contributions to the development of a new anticancer drug.”
October 3, 2013
Arvinas, Inc., a new biotech startup, is founded on the protein degradation technologies from the Crews Lab.
July 27, 2012
Carfilzomib/KyprolisTM, the next generation proteasome inhibitor developed in the Crews lab, received accelerated FDA approval for relapsed and refractory multiple myeloma.
May 1, 2012
GlaxoSmithKline announces a collaboration with the Crews lab to explore its PROTAC technology to control intracellular protein levels
October 1, 2011
Craig was selected as an Ellison Medical Foundation Senior Scholar in Aging
August 1, 2010
Craig has been appointed Gastprofessor at the Universität Konstanz.
June 1, 2010
Craig is named The Lewis B. Cullman Professor of Molecular, Cellular and Developmental Biology.
July 1, 2009
Yale Innovators profiles the Lab’s work on proteasome inhibitors.
June 1, 2009
Craig receives a Grand Challenges Exploration grant from the Bill & Melinda Gates Foundation.
February 2, 2009
Alessio Ciulli from the Abell Lab, University of Cambridge joins the lab as a postdoc, supported by a Human Frontier Science Program Fellowship.
December 1, 2008
Stephanie Leuenroth moves to a position at the US FDA.
September 1, 2008
Peter Gareiss joins us from the Miller Lab, University of Rochester.
July 1, 2008
Craig appointed Editor of Chemistry & Biology.
February 1, 2008
Seung-Yong Seo appointed Assistant Professor at Woosuk University, Korea.
October 1, 2007
Nicholas Aberle receives the Alcoa Foundation Fellowship from the American Australian Association.
July 2, 2007
Tim Corson receives a Canadian Institute of Health Research (CIHR) Postdoctoral Fellowship.
June 1, 2007
Leah Campbell receives a fellowship to study at the Marine Biological Laboratory.
May 1, 2007
Craig nominated to participate in the Yale China Trip as a member of the “Yale 100”
January 1, 2007
Pasquale Cirone recipient of Leukemia and Lymphoma Society Postdoctoral Fellowship.
October 2, 2006
Hüseyin Cavga recipient of the Feodor Lynen Research Scholarship from the Alexander von Humboldt Foundation.
September 4, 2006
Mathieu Pucheault appointed Assistant Professor at Université de Rennes 1.
August 1, 2006
Seung-Yong Seo recipient of the Korea Research Foundation Fellowship.
March 1, 2006
Nature Newsblog comments on Craig’s presentation at the National ACS Meeting in Atlanta.
March 1, 2006
Ashley Smith recipient of the National Science Foundation Graduate Research Fellowship.
February 1, 2006
Hyun Seop Tae recipient of the Korea Research Foundation Fellowship.
January 2, 2006
Craig receives the Friedrich Wilhelm Bessel Award from the Alexander von Humboldt Foundation.